CASI Pharmaceuticals Stock (NASDAQ: CASI)

CASI Pharmaceuticals (NASDAQ:CASI) Stock, Quote.Headers.trade-ideas

CASI Pharmaceuticals

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

pharma lab worker ai

Biotech

News

Health Care

Markets

Movers

Trading Ideas

General

CASI

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin&#39;s Lymphoma patients in China. Preliminary data reveals clinical efficacy with partial and complete responses, affirming positive safety profiles.

CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients

Penny Stocks

Small Cap

Pre-Market Outlook

AGIL

ATHX

BCEL

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

ELYS

ETWO

HYLN

MGRX

PRZO

SILK

SPCB

Tempest Therapeutics, Inc. - Common Stock

TPST

VINO

VOXX

WHLR

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

ABVC

AORT

ATXI

AVCT

BIAF

CCNC

CLLS

COST

CRKN

CSCW

CUEN

CWBR

CZOO

DRTS

EDAP

EEIQ

ELOX

ETRN

EVAX

EVTL

EZFL

FRGT

GOVX

GSUN

HHGC

HLGN

INBX

KITT

KRBP

LITM

NAOV

NEPT

PBLA

PRST

PTEN

PTPI

QBTS

RAVE

RDHL

REPX

RNXT

RUBY

SAVA

SBEV

SCHL

SCWO

SLCR

SOBR

SONX

SPPI

TELL

TTOO

VCNX

VIEW

VLON

XRTX

Gainers


	Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.


Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals Inc

Casino Guichard-Perrachon SA

CASINO GUICHARD PERRACHON by Casino Guichard Perrachon SA

Casino Guichard-Perrachon SA ADR

CASIO COMPUTER CO LTD by Casio Computer Co., Ltd.

Casio Computer Co Ltd

CASIO COMPUTER UNSP/ADR by Casio Computer Co., Ltd.

CASI Pharmaceuticals (CASI) announced that the Center for Drug Evaluation of China's National Medical Products Administration has approved the Comp...

Casi Pharmaceuticals receives CTA approval from China NMPA for CID-103

CASI Pharmaceuticals Q3 Earnings Preview

Here's the major earnings before the open tomorrow

CASI Pharmaceuticals reports Q3 results

CASI Pharmaceuticals (CASI) has released an update. CASI Pharmaceuticals reported a 12% decrease in third-quarter revenue in 2024 compared to the p...

CASI Pharmaceuticals' Mixed Third-Quarter Performance in 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.&nbsp; 1. STOCK NEWS: Shares of Domino's Pizza (DPZ) w...

Berkshire reveals stake in Domino's, Alibaba reports mixed Q2: Morning Buzz

CASI Pharmaceuticals ( ($CASI) ) has issued an update. CASI Pharmaceuticals has received a Termination Process Letter from Acrotech Biopharma regar...

CASI Pharmaceuticals Faces Evomela® License Termination Dispute

17:39 EST Casi Pharmaceuticals (CASI) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-movi...

Casi Pharmaceuticals files $200M mixed securities shelf

CASI Pharmaceuticals ( ($CASI) ) just unveiled an update. CASI Pharmaceuticals announced that the FDA has placed a clinical hold on its CID-103, an...

CASI Pharmaceuticals Faces Clinical Hold on CID-103 by FDA

CASI Pharmaceuticals (CASI) announced that the first patient has been dosed in the Phase 1/2 trial to evaluate the safety and tolerability of CID-1...

Casi Pharmaceuticals announces first patient dosed in Phase 1/2 trial of CID-103

AFMD

ALHC

AMAT

AMZN

ASTS

AZUL

BABA

BILI

BLUE

BTAI

CRIS

CVSI

DESP

DTEGY

EONGY

HALO

ITRM

KEYUF

KNTNF

LUNR

MKGAF

NICE

NLCP

NTES

OCUL

ONEW

PAVM

PDSB

POLA

PVCT

RCAT

SACH

SEDG

SIEGY

SLGL

SSNLF

TRUG

TWLO

VEON

VISL

WKHS

XNET

Press Releases

CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He

CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company

CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

Ligand Reports Second Quarter 2024 Financial Results

Earnings

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE

CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

Comments

CASI Pharmaceuticals

CASI Pharmaceuticals (CASI) Forecast

CASI Pharmaceuticals (NASDAQ:CASI) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga